|
1/30
Medicine: Three-Drug Therapy
May Suppress HIV
By Michael Waldholz
5/1
Medicine:
AIDS Fight Is Skewed By Federal Campaign Exaggerating Risks
Most Heterosexuals Face Scant Peril but Receive Large Portion of Funds --Less Goes to Gays, Addicts
By Amanda Bennett and Anita Sharpe
6/14
New Drug `Cocktails'
Mark Exciting Turn
In the War on AIDS
Companies Race to Market With `Protease Inhibitors'
After Good Test Results---`I Feel Wonderful, Incredible'
By Michael Waldholz
7/3
New AIDS
Treatment Raises Tough
Question Of Who Will Get It
For the Poor, High Costs, Rigid Regimens Dim Drug Cocktails' Promise--- A Major Issue for Medicaid
By Michael Waldholz
10/10
Medicine: Some AIDS Cases
Defy New Drug 'Cocktails'
By Michael Waldholz
11/5
Medicine:
Success of AIDS
Drug Has Merck Fighting
To Keep Up the Pace
Company Rushed Crixivan To Market; Now It Faces Production Bottleneck
--Watching the Patient-Count
By Elyse Tanouye
11/8
Back to a Future:
One Man's AIDS Tale
Shows How Quickly
Epidemic Has Turned
Last Year This Editor Wrote His Own Obituary; Now, He Writes of Surviving ---When It Was Called `GRID'
By David Sanford
11/15
Lack of Assurance:
Able to Work Again, AIDS Patients
Worry About Disability Pay
Forced to Make a Choice Between Job or Insurance, Many Opt for the Latter
--Taking a Carrier's Crawl Test
By George Anders
12/17
Drug Withdrawal:
Dr. Ho's Next Step
In AIDS Research Is
A Remarkable Gamble
He Wants to Test a 'Cure,' But Others Are Critical; A Talent for Sound Bites
--Irene Diamond's Dream Lab
By Michael Waldholz
12/20
Price of Success: Powerful Treatments Create
Growing Rift Among AIDS Groups
Social-Service Agencies Fear Losing Funds as Money Goes to Provide Medicine
---`I Want You Out of Business'
By Laurie McGinley
|